Given its functional properties and association with cancer processes (54, 73), TLN1 is indeed a potential drug for targeted therapy (74), but more investigation is needed to decipher how drugs should be developed to tackle protein action and/or TLN1 expression. Here, TLN1 is linked to cancer.